Novocure (NASDAQ: NVCR) has announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for use alongside PD-1/PD-L1 inhibitors or docetaxel. This treatment is intended for adult patients with metastatic non-small cell lung cancer (mNSCLC) who have…
Siemens Healthineers has announced a new prognostic claim for its Atellica IM High-Sensitivity Troponin I (TnIH) test, significantly enhancing care for at-risk cardiac patients in the U.S. This straightforward blood test allows healthcare providers to identify patients at risk of…
Airway Therapeutics, Inc. has announced the launch of a multinational Phase 3 clinical trial for zelpultide alfa (rhSP-D). This study aims to prevent bronchopulmonary dysplasia (BPD) and mitigate lung injury in premature infants. The biopharmaceutical company focuses on developing innovative…
Align Technology, Inc. (Nasdaq: ALGN), a global leader in medical devices known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, has announced the launch of its Invisalign Palatal Expander System in Hong Kong. This system is…
MEDiC Life Sciences, a prominent functional genomics startup in Silicon Valley, has announced a $5M strategic investment from LG and Hanmi Pharmaceutical. This funding precedes MEDiC’s upcoming Series-A round later this year. Previously, the company raised $8M in a Seed…
Heidelberg Engineering, a leader in ophthalmic imaging and healthcare data solutions, has announced FDA clearance for the SPECTRALIS® Flex Module. This innovative multimodal platform is specifically designed for diagnostic imaging of the posterior segment in both pediatric and adult patients…
MEDiC Life Sciences, a Silicon Valley biotech startup, has announced a research collaboration with Hanmi Pharmaceutical, a prominent biopharma company based in Korea. Through this partnership, MEDiC will utilize its MCAT™ platform to identify cancer biomarkers related to one of…
Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, have announced a clinical development collaboration. The partnership will evaluate the investigational tyrosine kinase inhibitor (TKI) zanzalintinib in combination with Merck’s anti-PD-1 therapy KEYTRUDA®…
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL), which provides a continuous range of vision with excellent tolerance…
GE HealthCare (Nasdaq: GEHC) has introduced the Versana Premier™, the latest addition to its Versana ultrasound family. This system is designed to be reliable, affordable, and user-friendly, offering versatile features for healthcare professionals. Equipped with automation and AI-powered productivity tools,…
Genentech, part of the Roche Group, shared encouraging two-year data from the ongoing RAINBOWFISH study at the 29th World Muscle Society Congress (October 8-12, 2024). This study evaluated the efficacy and safety of Evrysdi® (risdiplam) in children with spinal muscular…
Foundation Medicine, Inc. has announced FDA approval for FoundationOne® Liquid CDx as a companion diagnostic for Itovebi™ (inavolisib) when used with palbociclib (Ibrance®) and fulvestrant. This therapy, developed by Genentech, is designed for adult patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive,…